The effect of smoking on the response to nasal antigen challenge in patients with allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
The relation between atopic and non-atopic asthma and PPD response Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 490s Year: 2007
The effects of anti-IL-13 on allergen-induced responses; a Phase II study in subjects with mild atopic asthma - The allergen challenge as a model of allergic asthma for proof-of-concept studies Source: Annual Congress 2008 - Clinical trial - The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen-induced airway responses in subjects with mild atopic asthma Year: 2008
A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Allergen exposure in nondog and nonhouse dust mite sensitized atopic asthmatic subjects; effect on bronchial reactivity Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Expression of CCR3 in bronchial biopsies after allergen challenge in subjects with atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002
The structure of sensitization to aeroallergens in children with atopic bronchial asthma Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
A monoclonal antibody to IL-1B attenuates the late asthmatic response to antigen challenge in patients with mild asthma Source: Annual Congress 2006 - Novel treatments for asthma Year: 2006
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
Different immunoregulatory background in atopic and nonatopic asthma in children Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001
Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Plasma leukotriene level in atopic and non-atopic asthmatic children and its correlation to severity of the disease Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003
Specific serum IgE is associated with seasonal symptom load in children with allergic rhinitis Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Allergic inflammation in serum and sputum: comparison between healthy controls and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 393s Year: 2004
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Serum level of tryptase in atopic and non-atopic asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 585s Year: 2005
Comparison of blood ILC2 cell numbers, phenotypes and proliferation between atopic severe asthma participants, healthy controls with atopy and non-atopic healthy controls Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020